Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma
Clinical trial NCT03450850 · COMPLETED
Trial details
- NCT number
- NCT03450850
- Sponsor
- Daniela A. Bota
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-21
- Primary completion
- 2023-09-07
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.